FACIT’s Compass Rose Oncology Fund has invested in DNAstack. FACIT’s Prospects Oncology Fund initially invested in 2017.
Toronto based DNAstack is developing advanced data standards and technologies that make it easier for scientists to find, access, analyze and share complex and large volumes of multi-omics data in the cloud.
Latest posts by CPE Media News (see all)
- DNAstack secures new financing from FACIT - January 10, 2019
- Ether Capital invests US $1.5M in Wyre, Inc - December 14, 2018
- BLOK Technologies to acquire 80% of Worx Solutions for $800K - November 27, 2018